Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1995 Apr;103(4):366–371. doi: 10.1289/ehp.95103366

Dioxin activates HIV-1 gene expression by an oxidative stress pathway requiring a functional cytochrome P450 CYP1A1 enzyme.

Y Yao 1, A Hoffer 1, C Y Chang 1, A Puga 1
PMCID: PMC1519101  PMID: 7607137

Abstract

We have studied the effect of several environmental chemicals on the transient expression of a chloramphenicol acetyltransferase (cat) reporter gene linked to the promoter sequences in the long terminal repeat (LTR) of the human immunodeficiency virus type 1 (HIV-1). Aflatoxin B1, 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD; dioxin) and benzo[a]pyrene cause a significant increases in CAT expression in mouse hepatoma Hepa-1 cells. The induction of CAT after TCDD treatment is abolished by administration of N-acetyl-L-cysteine or 2-mercaptoethanol and does not take place in a mutant cell line that lacks CYP1A1 enzymatic activity. Linker-scanning mutational analysis of transcription factor binding sites in the promoter revealed that both the NF kappa B and an adjacent aromatic hydrocarbon response element (AhRE) are required for TCDD-dependent CAT expression. In addition, mutation of the NFAT/AP-1 binding sites in the negative regulatory region of the promoter increases the magnitude of the TCDD effect. We conclude that induction of a functional CYP1A1 monooxygenase by TCDD stimulates a pathway that generates thiol-sensitive reactive oxygen intermediates which, in turn, are responsible for the TCDD-dependent activation of genes linked to the LTR. These data might provide an explanation for findings that TCDD increases infectious HIV-1 titers in experimental systems and for epidemiologic reports suggesting that exposure to aromatic hydrocarbons, such as found in cigarette smoke, is associated with an acceleration in AIDS progression.

Full text

PDF
366

Images in this article

366p366-a
on p.366
368Figure 2.
on p.368
368Figure 3.
on p.368
369Figure 4.
on p.369
369Figure 5.
on p.369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abbott B. D., Birnbaum L. S. Cellular alterations and enhanced induction of cleft palate after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol. 1989 Jun 15;99(2):287–301. doi: 10.1016/0041-008x(89)90011-2. [DOI] [PubMed] [Google Scholar]
  2. Abbott B. D., Birnbaum L. S. TCDD-induced altered expression of growth factors may have a role in producing cleft palate and enhancing the incidence of clefts after coadministration of retinoic acid and TCDD. Toxicol Appl Pharmacol. 1990 Dec;106(3):418–432. doi: 10.1016/0041-008x(90)90337-t. [DOI] [PubMed] [Google Scholar]
  3. Abbott B. D., Harris M. W., Birnbaum L. S. Comparisons of the effects of TCDD and hydrocortisone on growth factor expression provide insight into their interaction in the embryonic mouse palate. Teratology. 1992 Jan;45(1):35–53. doi: 10.1002/tera.1420450104. [DOI] [PubMed] [Google Scholar]
  4. Bernhard H. P., Darlington G. J., Ruddle F. H. Expression of liver phenotypes in cultured mouse hepatoma cells: synthesis and secretion of serum albumin. Dev Biol. 1973 Nov;35(1):83–96. doi: 10.1016/0012-1606(73)90008-0. [DOI] [PubMed] [Google Scholar]
  5. Boulos R., Halsey N. A., Holt E., Ruff A., Brutus J. R., Quinn T. C., Adrien M., Boulos C. HIV-1 in Haitian women 1982-1988. The Cite Soleil/JHU AIDS Project Team. J Acquir Immune Defic Syndr. 1990;3(7):721–728. [PubMed] [Google Scholar]
  6. Burns D. N., Kramer A., Yellin F., Fuchs D., Wachter H., DiGioia R. A., Sanchez W. C., Grossman R. J., Gordin F. M., Biggar R. J. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr. 1991;4(1):76–83. [PubMed] [Google Scholar]
  7. Canga L., Levi R., Rifkind A. B. Heart as a target organ in 2,3,7,8-tetrachlorodibenzo-p-dioxin toxicity: decreased beta-adrenergic responsiveness and evidence of increased intracellular calcium. Proc Natl Acad Sci U S A. 1988 Feb;85(3):905–909. doi: 10.1073/pnas.85.3.905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Canga L., Paroli L., Blanck T. J., Silver R. B., Rifkind A. B. 2,3,7,8-tetrachlorodibenzo-p-dioxin increases cardiac myocyte intracellular calcium and progressively impairs ventricular contractile responses to isoproterenol and to calcium in chick embryo hearts. Mol Pharmacol. 1993 Dec;44(6):1142–1151. [PubMed] [Google Scholar]
  9. Capdevila J. H., Falck J. R., Estabrook R. W. Cytochrome P450 and the arachidonate cascade. FASEB J. 1992 Jan 6;6(2):731–736. doi: 10.1096/fasebj.6.2.1537463. [DOI] [PubMed] [Google Scholar]
  10. Capdevila J. H., Karara A., Waxman D. J., Martin M. V., Falck J. R., Guenguerich F. P. Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem. 1990 Jul 5;265(19):10865–10871. [PubMed] [Google Scholar]
  11. Capdevila J., Gil L., Orellana M., Marnett L. J., Mason J. I., Yadagiri P., Falck J. R. Inhibitors of cytochrome P-450-dependent arachidonic acid metabolism. Arch Biochem Biophys. 1988 Mar;261(2):257–263. doi: 10.1016/0003-9861(88)90340-2. [DOI] [PubMed] [Google Scholar]
  12. Chang K. S., Hsu M. L., Josephs S. F. Regulation of HIV-1 LTR trans-activating activities in two different human hepatocellular carcinoma cell lines. Cancer Lett. 1993 Oct 15;74(1-2):75–83. doi: 10.1016/0304-3835(93)90047-d. [DOI] [PubMed] [Google Scholar]
  13. Clarke J. R., Taylor I. K., Fleming J., Nukuna A., Williamson J. D., Mitchell D. M. The epidemiology of HIV-1 infection of the lung in AIDS patients. AIDS. 1993 Apr;7(4):555–560. doi: 10.1097/00002030-199304000-00015. [DOI] [PubMed] [Google Scholar]
  14. Couture L. A., Abbott B. D., Birnbaum L. S. A critical review of the developmental toxicity and teratogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin: recent advances toward understanding the mechanism. Teratology. 1990 Dec;42(6):619–627. doi: 10.1002/tera.1420420606. [DOI] [PubMed] [Google Scholar]
  15. Fingerhut M. A., Halperin W. E., Marlow D. A., Piacitelli L. A., Honchar P. A., Sweeney M. H., Greife A. L., Dill P. A., Steenland K., Suruda A. J. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 1991 Jan 24;324(4):212–218. doi: 10.1056/NEJM199101243240402. [DOI] [PubMed] [Google Scholar]
  16. Flodström S., Busk L., Kronevi T., Ahlborg U. G. Modulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin and phenobarbital-induced promotion of hepatocarcinogenesis in rats by the type of diet and vitamin A deficiency. Fundam Appl Toxicol. 1991 Feb;16(2):375–391. [PubMed] [Google Scholar]
  17. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS. 1992 Apr;6(4):347–363. doi: 10.1097/00002030-199204000-00001. [DOI] [PubMed] [Google Scholar]
  18. Gendelman H. E., Phelps W., Feigenbaum L., Ostrove J. M., Adachi A., Howley P. M., Khoury G., Ginsberg H. S., Martin M. A. Trans-activation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9759–9763. doi: 10.1073/pnas.83.24.9759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973 Apr;52(2):456–467. doi: 10.1016/0042-6822(73)90341-3. [DOI] [PubMed] [Google Scholar]
  20. Hankinson O., Andersen R. D., Birren B. W., Sander F., Negishi M., Nebert D. W. Mutations affecting the regulation of transcription of the cytochrome P1-450 gene in the mouse Hepa-1 cell line. J Biol Chem. 1985 Feb 10;260(3):1790–1795. [PubMed] [Google Scholar]
  21. Hankinson O. Dominant and recessive aryl hydrocarbon hydroxylase-deficient mutants of mouse hepatoma line, Hepa-1, and assignment of recessive mutants to three complementation groups. Somatic Cell Genet. 1983 Jul;9(4):497–514. doi: 10.1007/BF01543050. [DOI] [PubMed] [Google Scholar]
  22. Hsu J. C., Bravo R., Taub R. Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol. 1992 Oct;12(10):4654–4665. doi: 10.1128/mcb.12.10.4654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem. 1994;63:717–743. doi: 10.1146/annurev.bi.63.070194.003441. [DOI] [PubMed] [Google Scholar]
  24. Kanetoshi A., Ward A. M., May B. K., Rifkind A. B. Immunochemical identity of the 2,3,7,8-tetrachlorodibenzo-p-dioxin- and beta-naphthoflavone-induced cytochrome P-450 arachidonic acid epoxygenases in chick embryo liver: distinction from the omega-hydroxylase and the phenobarbital-induced epoxygenase. Mol Pharmacol. 1992 Dec;42(6):1020–1026. [PubMed] [Google Scholar]
  25. Kimura S., Smith H. H., Hankinson O., Nebert D. W. Analysis of two benzo[a]pyrene-resistant mutants of the mouse hepatoma Hepa-1 P(1)450 gene via cDNA expression in yeast. EMBO J. 1987 Jul;6(7):1929–1933. doi: 10.1002/j.1460-2075.1987.tb02453.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Knutson J. C., Poland A. Response of murine epidermis to 2,3,7,8-tetrachlorodibenzo-p-dioxin: interaction of the ah and hr loci. Cell. 1982 Aug;30(1):225–234. doi: 10.1016/0092-8674(82)90028-9. [DOI] [PubMed] [Google Scholar]
  27. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Dittenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D. Results of a two-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats. Toxicol Appl Pharmacol. 1978 Nov;46(2):279–303. doi: 10.1016/0041-008x(78)90075-3. [DOI] [PubMed] [Google Scholar]
  28. Landers J. P., Bunce N. J. The Ah receptor and the mechanism of dioxin toxicity. Biochem J. 1991 Jun 1;276(Pt 2):273–287. doi: 10.1042/bj2760273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Lentnek M., Griffith O. W., Rifkind A. B. 2,3,7,8-Tetrachlorodibenzo-p-dioxin increases reliance on fats as a fuel source independently of diet: evidence that diminished carbohydrate supply contributes to dioxin lethality. Biochem Biophys Res Commun. 1991 Feb 14;174(3):1267–1271. doi: 10.1016/0006-291x(91)91558-t. [DOI] [PubMed] [Google Scholar]
  30. Lu Y. C., Touzjian N., Stenzel M., Dorfman T., Sodroski J. G., Haseltine W. A. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J Virol. 1990 Oct;64(10):5226–5229. doi: 10.1128/jvi.64.10.5226-5229.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lu Y. C., Touzjian N., Stenzel M., Dorfman T., Sodroski J. G., Haseltine W. A. The NF kappa B independent cis-acting sequences in HIV-1 LTR responsive to T-cell activation. J Acquir Immune Defic Syndr. 1991;4(2):173–177. [PubMed] [Google Scholar]
  32. Manz A., Berger J., Dwyer J. H., Flesch-Janys D., Nagel S., Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991 Oct 19;338(8773):959–964. doi: 10.1016/0140-6736(91)91835-i. [DOI] [PubMed] [Google Scholar]
  33. McConkey D. J., Hartzell P., Duddy S. K., Håkansson H., Orrenius S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation. Science. 1988 Oct 14;242(4876):256–259. doi: 10.1126/science.3262923. [DOI] [PubMed] [Google Scholar]
  34. McConkey D. J., Orrenius S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) kills glucocorticoid-sensitive thymocytes in vivo. Biochem Biophys Res Commun. 1989 May 15;160(3):1003–1008. doi: 10.1016/s0006-291x(89)80101-9. [DOI] [PubMed] [Google Scholar]
  35. McKnight S. L., Kingsbury R. Transcriptional control signals of a eukaryotic protein-coding gene. Science. 1982 Jul 23;217(4557):316–324. doi: 10.1126/science.6283634. [DOI] [PubMed] [Google Scholar]
  36. Nakai K., Ward A. M., Gannon M., Rifkind A. B. Beta-naphthoflavone induction of a cytochrome P-450 arachidonic acid epoxygenase in chick embryo liver distinct from the aryl hydrocarbon hydroxylase and from phenobarbital-induced arachidonate epoxygenase. J Biol Chem. 1992 Sep 25;267(27):19503–19512. [PubMed] [Google Scholar]
  37. Nebert D. W., Gonzalez F. J. P450 genes: structure, evolution, and regulation. Annu Rev Biochem. 1987;56:945–993. doi: 10.1146/annurev.bi.56.070187.004501. [DOI] [PubMed] [Google Scholar]
  38. Nebert D. W. The Ah locus: genetic differences in toxicity, cancer, mutation, and birth defects. Crit Rev Toxicol. 1989;20(3):153–174. doi: 10.3109/10408448909017908. [DOI] [PubMed] [Google Scholar]
  39. Nieman R. B., Fleming J., Coker R. J., Harris J. R., Mitchell D. M. The effect of cigarette smoking on the development of AIDS in HIV-1-seropositive individuals. AIDS. 1993 May;7(5):705–710. doi: 10.1097/00002030-199305000-00015. [DOI] [PubMed] [Google Scholar]
  40. Northrop J. P., Ullman K. S., Crabtree G. R. Characterization of the nuclear and cytoplasmic components of the lymphoid-specific nuclear factor of activated T cells (NF-AT) complex. J Biol Chem. 1993 Feb 5;268(4):2917–2923. [PubMed] [Google Scholar]
  41. Perkins N. D., Edwards N. L., Duckett C. S., Agranoff A. B., Schmid R. M., Nabel G. J. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J. 1993 Sep;12(9):3551–3558. doi: 10.1002/j.1460-2075.1993.tb06029.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Pizzella T., Banerjee R. Identification of a human immunodeficiency virus type 1 TAR binding protein in human hepatoblastoma HepG2 cells that trans-activates HIV-1 LTR-directed gene expression. DNA Cell Biol. 1994 Jan;13(1):67–74. doi: 10.1089/dna.1994.13.67. [DOI] [PubMed] [Google Scholar]
  43. Pokrovsky A. G., Cherykh A. I., Yastrebova O. N., Tsyrlov I. B. 2,3,7,8-Tetrachlorodibenzo-P-dioxin as a possible activator of HIV infection. Biochem Biophys Res Commun. 1991 Aug 30;179(1):46–51. doi: 10.1016/0006-291x(91)91331-6. [DOI] [PubMed] [Google Scholar]
  44. Poland A., Knutson J. C. 2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity. Annu Rev Pharmacol Toxicol. 1982;22:517–554. doi: 10.1146/annurev.pa.22.040182.002505. [DOI] [PubMed] [Google Scholar]
  45. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 1982 Nov 18;300(5889):271–273. doi: 10.1038/300271a0. [DOI] [PubMed] [Google Scholar]
  46. Puga A., Nebert D. W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 1992 May;11(4):269–281. doi: 10.1089/dna.1992.11.269. [DOI] [PubMed] [Google Scholar]
  47. Puga A., Raychaudhuri B., Salata K., Zhang Y. H., Nebert D. W. Stable expression of mouse Cyp1a1 and human CYP1A2 cDNAs transfected into mouse hepatoma cells lacking detectable P450 enzyme activity. DNA Cell Biol. 1990 Jul-Aug;9(6):425–436. doi: 10.1089/dna.1990.9.425. [DOI] [PubMed] [Google Scholar]
  48. Rifkind A. B., Gannon M., Gross S. S. Arachidonic acid metabolism by dioxin-induced cytochrome P-450: a new hypothesis on the role of P-450 in dioxin toxicity. Biochem Biophys Res Commun. 1990 Nov 15;172(3):1180–1188. doi: 10.1016/0006-291x(90)91573-b. [DOI] [PubMed] [Google Scholar]
  49. Roederer M., Staal F. J., Raju P. A., Ela S. W., Herzenberg L. A., Herzenberg L. A. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine. Proc Natl Acad Sci U S A. 1990 Jun;87(12):4884–4888. doi: 10.1073/pnas.87.12.4884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 1991 Aug;10(8):2247–2258. doi: 10.1002/j.1460-2075.1991.tb07761.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Schüller H. M. The signal transduction model of carcinogenesis. Biochem Pharmacol. 1991 Sep 27;42(8):1511–1523. doi: 10.1016/0006-2952(91)90419-6. [DOI] [PubMed] [Google Scholar]
  52. Seed B., Sheen J. Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 1988 Jul 30;67(2):271–277. doi: 10.1016/0378-1119(88)90403-9. [DOI] [PubMed] [Google Scholar]
  53. Southgate C. D., Green M. R. The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes Dev. 1991 Dec;5(12B):2496–2507. doi: 10.1101/gad.5.12b.2496. [DOI] [PubMed] [Google Scholar]
  54. Staal F. J., Roederer M., Herzenberg L. A., Herzenberg L. A. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci U S A. 1990 Dec;87(24):9943–9947. doi: 10.1073/pnas.87.24.9943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Suskind R. R. Chloracne, "the hallmark of dioxin intoxication". Scand J Work Environ Health. 1985 Jun;11(3 Spec No):165–171. doi: 10.5271/sjweh.2240. [DOI] [PubMed] [Google Scholar]
  56. Swanson H. I., Bradfield C. A. The AH-receptor: genetics, structure and function. Pharmacogenetics. 1993 Oct;3(5):213–230. doi: 10.1097/00008571-199310000-00001. [DOI] [PubMed] [Google Scholar]
  57. Tong-Starksen S. E., Welsh T. M., Peterlin B. M. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals. J Immunol. 1990 Dec 15;145(12):4348–4354. [PubMed] [Google Scholar]
  58. Tsyrlov I. B., Pokrovsky A. Stimulatory effect of the CYP1A1 inducer 2,3,7,8-tetrachlorodibenzo-p-dioxin on the reproduction of HIV-1 in human lymphoid cell culture. Xenobiotica. 1993 Apr;23(4):457–467. doi: 10.3109/00498259309057034. [DOI] [PubMed] [Google Scholar]
  59. Wang Z., Goldberg M. A., Scadden D. T. HIV-1 suppresses erythropoietin production in vitro. Exp Hematol. 1993 May;21(5):683–688. [PubMed] [Google Scholar]
  60. Whitlock J. P., Jr Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. Annu Rev Pharmacol Toxicol. 1990;30:251–277. doi: 10.1146/annurev.pa.30.040190.001343. [DOI] [PubMed] [Google Scholar]
  61. Whitlock J. P., Jr The regulation of gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Pharmacol Rev. 1987 Jun;39(2):147–161. [PubMed] [Google Scholar]
  62. Zugerman C. Chloracne. Clinical manifestations and etiology. Dermatol Clin. 1990 Jan;8(1):209–213. [PubMed] [Google Scholar]
  63. van der Meulen J. C., Vaandrager J. M. Facial clefts. World J Surg. 1989 Jul-Aug;13(4):373–383. doi: 10.1007/BF01660750. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES